Really? Articles from early 2014 say 4 plants are banned, while Ranbaxy's website boasts 21 manufacturing locations.
Sun Pharma, which is buying (or bought?) Ranbaxy, recently got a plant ban for the same types of issues. (They delete test info if it isn't in their favour, and have terrible hygiene at the labs.) It's obviously endemic. And Sun quickly noted that the ban only affects 1% of their revenue.
It seems unbelievable that this deep level of corruption is exposed, and the FDA does limited bans and recalls. Instead of, say, completely banning the company and high-level individuals involved, until a complete end-to-end audit is completed. It's simply counterfactual to think these limited bans are accomplishing anything, or that a company is going to utterly and completely change the way they conduct themselves from individual techs all the way up to the board.
The Fortune article says none of the FDA inspectors would ever personally buy drugs from Ranbaxy, ban or not.
Articles from early 2014 say 4 plants are banned, while Ranbaxy's website boasts 21 manufacturing locations.
Interesting, I looked it up and yes, the FDA is banning each plant separately. One could argue that the FDA can only ban the plants they find problems at, however, I would agree with you that Ranbaxy's behavior is bad enough to stop all shipments into the US. Not sure why the FDA decided to be more lenient. Maybe the law governing the FDA limits how far it can go? I don't know.
Sun Pharma, which is buying (or bought?) Ranbaxy, recently got a plant ban for the same types of issues. (They delete test info if it isn't in their favour, and have terrible hygiene at the labs.) It's obviously endemic. And Sun quickly noted that the ban only affects 1% of their revenue.
It seems unbelievable that this deep level of corruption is exposed, and the FDA does limited bans and recalls. Instead of, say, completely banning the company and high-level individuals involved, until a complete end-to-end audit is completed. It's simply counterfactual to think these limited bans are accomplishing anything, or that a company is going to utterly and completely change the way they conduct themselves from individual techs all the way up to the board.
The Fortune article says none of the FDA inspectors would ever personally buy drugs from Ranbaxy, ban or not.